REDHILL BIOPHARMA LTD-SP ADR (RDHL) Stock Analyst Ratings
USA - NASDAQ:RDHL - US7574683014 - ADR
1.64 USD
-0.09 (-5.2%)
1.6101 USD
-0.03 (-1.82%)
ChartMill assigns a Buy % Consensus number of 83% to RDHL. The Buy consensus is the weighted average rating of the current analysts ratings.
RDHL was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about RDHL.
In the previous month the buy percentage consensus was at a similar level.
RDHL was analyzed by 7 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-09-15 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-31 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-05-28 | WBB Securities | Downgrade | Strong Buy -> Buy |
| 2021-05-18 | HC Wainwright & Co. | Initiate | Buy |
REDHILL BIOPHARMA LTD-SP ADR / RDHL FAQ
Can you provide the consensus rating for REDHILL BIOPHARMA LTD-SP ADR stock?
The consensus rating for REDHILL BIOPHARMA LTD-SP ADR (RDHL) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover REDHILL BIOPHARMA LTD-SP ADR (RDHL) stock?
The number of analysts covering REDHILL BIOPHARMA LTD-SP ADR (RDHL) is 7.